Hormone Replacement Therapy (HRT) is a hotly debated topic. It has benefits and risks, and we found a very interesting person to discuss all of that with: Katie Taylor, founder of The Latte Lounge and daughter of an eminent breast cancer surgeon, Professor Michael Baum. Katie recently went to Westminster with some of her colleagues, to meet with the Health secretary to campaign for better menopause support. She also spoke last year at the largest UK Mental Health Conference ‘This Can Happen’ about Menopause in the Work Place. Last summer she won The ‘Work Avenue Entrepreneur of The Year’ award beating off stiff competition. She also won the Highly Commended Mpower Mums in Business Award this year and was listed as one of the 10 women to watch in 2019 by About Time Magazine. She has things to say about women’s health and menopause, and we know you’ll find this podcast electrifying and motivating!
Learn more about Fit2B membership here!
The Interview with Professor Michael Baum
FREE Menopause Symptom Checker
Sign the petition to “Make Menopause Matter” here!
Visit The Latte Lounge FB group which Katie set up 3 years ago for Women Over 40 because she had suffered debilitating perimenopausal symptoms for 4 years which were misdiagnosed as depression and forced her to give up 3 jobs. Eventually she was put on HRT and turned to Facebook to express her frustration and anger that she had wasted 4 precious years of life due to badly trained General Practicioners. Within one day, the group attracted 2,000 members and now almost 3 years on it has over 16,000 women over 40 in 69 countries growing organically at a rate of 100 new members a week.
One thought on “S2:9 The One About HRT With Katie Taylor”
I just wanted to share that the cost of HRT is not inconsequential and may be more than a few hundred dollars. I have just started bio identical HRT as a post menopausal woman after a year of deliberation because it will cost over $3000 for the year’s treatment. I have read the book mentioned in the podcast, Estrogen Matters, and it was instrumental in convincing me that the financial investment in my future health (in terms of risk reduction for cardiovascular disease and dementia) was worth the financial cost. It is unlikely that this treatment will be counted toward my deductible so it is all out of pocket and may become unsustainable in my future.